Koninklijke Philips N.V. (PHG) Stock Price & Analysis
Koninklijke Philips N.V. (PHG) — MoonshotScore 74/100 (Strong band), calculated Oct 5, 2026. Price $23.92 (+0.46%), as of the Oct 2, 2026 trading session; market cap $23.4B. Expected results Nov 3, 2026.
Educational signal · not a buy or sell recommendation · How to read this
Koninklijke Philips N.V. · PHG · NYSE · Healthcare · Medical - Devices
Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment; Connected Care; Personal Health; and Other.
Price as of Oct 2, 2026
Key Statistics
MoonshotScore v2 · Koninklijke Philips (PHG)
StrongWhy this rating? Method, drivers & history
Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.
- Business Quality — Is this a genuinely good business?
- Financial Safety — Could this blow up on me?
- Valuation — Am I paying a fair price?
- Growth Durability — Is the growth real and likely to last?
- Momentum — Is the market already moving on this?
High quality, at a cheap price, though the balance sheet and growth are only middling. Business Quality: Elite; Financial Safety: Okay; Valuation: Cheap; Growth Durability: Flat; Momentum: Quiet.
- quarterly revenue $4.88B (Q2 FY2026, quarter ended Jun 2026)
- EPS beat 5 of 8
- Altman Z 1.96 · Piotroski F 7
Helping: business quality, an attractive price
What has the MoonshotScore done over time?
| Recorded | Score | Band |
|---|---|---|
| 74 | Strong | |
| 74 | Strong | |
| 74 | Strong | |
| 74 | Strong | |
| 75 | Strong | |
| 75 | Strong |
The score was 74 in the stored Oct 4, 2026 snapshot and remains 74 in the current publication computed Oct 5, 2026 (0); the largest pillar moves were Growth Durability +1; the pillar moves offset under the sector-relative weighting, so the headline score is unchanged. This current publication is not yet represented in the immutable snapshot archive.
Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.
Computed · Educational signal · not a buy or sell recommendation · How the MoonshotScore is computed →
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $23.92 | |
| Change on the day | +0.46% | |
| 52-week range | $23.70 – $33.44 | |
| Market capitalisation | $23.4B | |
| Price / earnings (trailing) | 18.18 | |
| Shares traded on the day | 836.3K | |
| Beta (volatility vs the S&P 500) | 0.92 | |
| Dividends per share (last 12 months) | $0.99 | |
| Dividend yield (last 12 months) | 4.14% |
Price & events
Triangles mark reported quarters on the line: pointing up is above the recorded estimate, down is below, a diamond means no estimate on file or a dated event that is not a results report. Numbers key to the dated list. Point at or tab to any week for its close.
Events behind the price
- · Earnings results · in line with the recorded estimate
- · Earnings results · above the recorded estimate
- · Earnings results · above the recorded estimate
- · Earnings results · above the recorded estimate
- · Earnings call · management outlook
Results dates follow the earnings feed; call dates follow the transcript provider. Nearby dates do not establish that an event caused a price move.
Upcoming events
Management outlook
Excluding the tariff refund benefit, we continue to expect a full year adjusted EBITA margin of 12.5% to 13%.
Roy Jakobs · Statement from
Excluding the tariff refund, we continue to expect a full year adjusted EBITA margin of between 12.5% and 13%, driven by sales growth, innovation and productivity, partially offset by annualized tariffs and input cost inflation.
Charlotte Hanneman · Statement from
Statement dates identify the earnings call, not a deadline. Management expectations and provider estimates can change.
Read management statementsCouncil Score · weighted blend of 2 available disciplines
Council score for Koninklijke Philips (PHG): Bullish Lean
69/100 · B+Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
5-Factor Breakdown
Legends Council
6 lenses, 6 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Oct 5, 2026
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Sep 11, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Sep 11, 2026, the Munger lens read the price at that time as undervalued against its own estimate of value.
Readings on this page are from Oct 5, 2026, except a card that shows its own read date.
Watch the PHG film — every key number, told as a short cinematic story
~2 min · open the film
What is Koninklijke Philips (PHG), and what does it report?
Short answer · as of
Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment; Connected Care; Personal Health; and Other. Koninklijke Philips N.V. (PHG) is listed on NYSE. Healthcare / Medical Devices SEC filing business address: Prinses Irenestraat 59, Amsterdam, 1077WV. It employs 66,401 people and is led by Roy W. O. Jakobs. In Q2 FY2026 it reported revenue of $4.88B and net income of $429M. The market values it at $23.4B.
What do the latest results show for Koninklijke Philips (PHG)?
Short answer · as of
The most recent reported quarter, Q2 FY2026, carried revenue of $4.88B. Against analyst estimates the company has EPS beat 5 of 8 reports.
Did results meet expectations?
Reported earnings and revenue alongside the estimates recorded by the provider.
- Latest report · revenue
- $4.96B Jul 27, 2026
- Latest report · revenue estimate
- $4.91B Jul 27, 2026
- Latest report · revenue vs estimate
- Above estimate Jul 27, 2026
- Latest report · EPS vs estimate
- Above estimate Jul 27, 2026
| Report date | Revenue · reported | Revenue · estimate | EPS · reported | EPS · estimate |
|---|---|---|---|---|
| Jul 27, 2026 | $4.96B | $4.91B | $0.5700 | $0.4000 |
| May 6, 2026 | $4.59B | $4.49B | $0.2700 | $0.2400 |
| Feb 10, 2026 | $6.07B | $5.89B | $0.7000 | $0.5650 |
| Nov 4, 2025 | $5.04B | $5.03B | $0.3700 | $0.3700 |
Dates are report dates, not fiscal period ends. Revenue is in USD; EPS is USD per share, rounded to four decimals. The earnings feed does not establish a basic, diluted or adjusted basis. Earnings-feed EPS may differ from statement EPS; the two series are not combined.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q2 FY2026 | $4.88B | $429M | $0.44 (diluted) |
| Q1 FY2026 | $4.37B | $169M | $0.17 (diluted) |
| Q4 FY2025 | $5.70B | $442M | $0.46 (diluted) |
| Q3 FY2025 | $4.81B | $206M | $0.21 (diluted) |
What are the financial strengths and risks for Koninklijke Philips (PHG)?
Short answer
The MoonshotScore pillars rate business quality, an attractive price as strengths. The distress and quality screens read Altman Z 1.96 · Piotroski F 7. Trailing ratios: ROE 10.0% · ROA 4.2% · current ratio 1.26 · earnings yield 5.3% · free-cash-flow yield 8.8%.
What should you watch next at Koninklijke Philips (PHG)?
Short answer · as of
The next earnings report is expected on Nov 3, 2026.
What management is planning
Management expectations, not completed milestones or guarantees. Selected verbatim excerpts; dates follow the transcript provider.
Excluding the tariff refund benefit, we continue to expect a full year adjusted EBITA margin of 12.5% to 13%.
Roy Jakobs ·
Excluding the tariff refund, we continue to expect a full year adjusted EBITA margin of between 12.5% and 13%, driven by sales growth, innovation and productivity, partially offset by annualized tariffs and input cost inflation.
Charlotte Hanneman ·
For Q3, we expect adjusted EBITA margin to be below the prior year level, primarily reflecting higher cost inflation and an unfavorable mix impact.
Charlotte Hanneman ·
Indeed, Q3, we expect the adjusted margin to be slightly below the prior-year level as a result of inflation that is, of course, still coming through as well as unfavorable mix.
Charlotte Hanneman ·
What the records here don't tell us
- Detailed statement figures are not shown because their conversion to USD has not been verified.
- No insider Form 4 transaction falls inside the window this page reads.
Checked against the records this page reads, on the dates shown above.
How does Koninklijke Philips compare with its peers?
Short answer
Koninklijke Philips's score ranks 10th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.
Research dated 2026-09-12.
Unlike a focused hospital equipment vendor, Philips combines diagnostic and treatment platforms with monitoring, respiratory care, enterprise informatics, and branded consumer health products. Its results therefore reflect purchasing by health systems as well as demand for oral care, personal care, and mother-and-child products.
That breadth makes product mix economically important: which Philips products sell matters alongside how much the company sells. Management's warning about unfavorable mix confirms that shifts within the portfolio can pressure margins even without a broad revenue contraction.
| Company | Price | Market value | Score |
|---|---|---|---|
| $85.36 Oct 2, 2026 | $32.2B | 96 5-pillar Oct 5, 2026 | |
| $75.60 Oct 2, 2026 | $10.2B | 96 5-pillar Oct 5, 2026 | |
| $317.55 Oct 2, 2026 | $12.5B | 95 5-pillar Oct 5, 2026 | |
| $85.15 Oct 2, 2026 | $49.0B | 90 5-pillar Oct 5, 2026 | |
| $208.54 Oct 2, 2026 | $20.3B | 87 5-pillar Oct 5, 2026 | |
| $26.42 Oct 2, 2026 | $11.1B | 87 5-pillar Oct 5, 2026 | |
| $143.74 Oct 2, 2026 | $10.3B | 83 5-pillar Oct 5, 2026 | |
| $1486.19 Oct 2, 2026 | $30.0B | 82 5-pillar Oct 5, 2026 | |
| $88.29 Oct 2, 2026 | $17.1B | 80 5-pillar Oct 5, 2026 | |
| Koninklijke Philips (PHG) — this page | $23.92 | $23.4B | 74 |
| $39.53 Oct 2, 2026 | $46.0B | 66 5-pillar Oct 5, 2026 | |
| $63.24 Oct 2, 2026 | $9.63B | 59 5-pillar Oct 5, 2026 | |
| $96.90 Oct 2, 2026 | $24.3B | 52 5-pillar Oct 5, 2026 |
Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.
The records behind this page
Who holds the shares?
Institutional ownership reported through 13F filings.
- Institutional ownership
- 5.4% Period end Jun 30, 2026
- Previous quarter · ownership
- 5.4% Prior to period end Jun 30, 2026
- Reporting holders
- 376 Period end Jun 30, 2026
- Previous quarter · holders
- 352 Prior to period end Jun 30, 2026
| Holders in provider snapshot | Shares |
|---|---|
| Mondrian Investment Partners Ltd | 8,067,528 |
| Dimensional Fund Advisors LP | 4,340,691 |
| Fiduciary Management INC /Wi/ | 3,459,961 |
| Causeway Capital Management LLC | 3,061,962 |
| Morgan Stanley | 2,935,662 |
Quarterly filings lag the period end. Holder rows are names in the provider snapshot, not a verified ranking; individual filing dates are not supplied. Related managers may appear separately, so these positions are not summed. Holder snapshot as of Jun 30, 2026.
What has been published about Koninklijke Philips (PHG)?
What Investors Ask About Koninklijke Philips (PHG) — Healthcare
Research dated 2026-09-12; the answers below are from that research, and the full attribution is under Sources. The last 2 questions are answered from this page's own dated data, not from the research.
What does Philips sell beyond diagnosis and treatment systems?
Philips also supplies patient monitoring, sleep and respiratory care, and enterprise informatics, while Personal Health covers oral care, personal care, and mother-and-child products.
What is pressuring Philips adjusted margin?
Management identifies input-cost inflation, annualized tariffs, and an unfavorable product mix as offsets to innovation, productivity, and sales growth.
How does Philips Personal Health change its business exposure?
Personal Health adds oral care, personal care, and mother-and-child products to a portfolio otherwise centered on hospital systems, clinical devices, software, and care services. Philips is therefore not a pure hospital-equipment business.
What is the PHG stock price today?
The last price recorded on this page for Koninklijke Philips N.V. (PHG) is $23.92, as of the Oct 2, 2026 trading session (source: Financial Modeling Prep (FMP) · quote). It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
Does PHG pay a dividend?
Yes. Koninklijke Philips N.V. (PHG) shows a trailing 12-month dividend yield of 4.14%, as of Oct 2, 2026, in the data on this page. Payout ratio and cash-flow coverage decide whether it can last, and past dividends do not guarantee future payments.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Research written by Codex (gpt-5.6-sol) on 2026-09-12. AI-authored analysis; source dates are shown with each answer. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources — records for every figure on this page (53 figures)
The 53 rows below are exactly the facts the evidence-backed sections of this page printed — the 10-second verdict, the MoonshotScore, price and market value, the five questions with their receipts, and the records behind this page. Known dates and sources are recorded on their own rows; an em dash or UNRECORDED tier preserves a stored observation without inventing either. The quarterly income statement is provider-standardized (FMP) under one row, and scale definitions — a 0-100 rating, the band ladder, the Piotroski 0–9 range — are fixed rather than measured. No number in those sections was generated by a model. The register does not cover quoted third-party headlines, the dated council readings, or the Frequently Asked Questions; each of those says where it came from where it stands.
"As of" is the date the value is true for where the source carries one — a quarter end, a filing date, a price close, the day the score was computed. A cached observation with no source date remains undated; the page publication date is not used as a substitute.
OFFICIAL — 2 facts from SEC filings and earnings calls
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
prod.outlook | Management outlook — call excerpts | Roy Jakobs (Jul 28, 2026): Excluding the tariff refund benefit, we continue to expect a full year adjusted EBITA margin of 12.5% to 13%. Charlotte Hanneman (Jul 28, 2026): Excluding the tariff refund, we continue to expect a full year adjusted EBITA margin of between 12.5% and 13%, driven by sales growth, innovation and productivity, partially offset by annualized tariffs and input cost inflation. Charlotte Hanneman (Jul 28, 2026): For Q3, we expect adjusted EBITA margin to be below the prior year level, primarily reflecting higher cost inflation and an unfavorable mix impact. Charlotte Hanneman (Jul 28, 2026): Indeed, Q3, we expect the adjusted margin to be slightly below the prior-year level as a result of inflation that is, of course, still coming through as well as unfavorable mix. | OFFICIAL | Company earnings call, transcript via Financial Modeling Prep (FMP) — Selected verbatim statements from the latest available call, dated by the transcript provider. Management expectations, not completed milestones or guarantees. Relative dates retain the speaker's wording. | |
id.hq | SEC filing business address | Prinses Irenestraat 59, Amsterdam, 1077WV | OFFICIAL | SEC EDGAR filer business address — The SEC filer business address. Our market-data provider separately lists "Philips Center, Amsterdam, NH, 1077 WV, NL". |
FMP — 40 facts from Financial Modeling Prep endpoint families
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
px.last | Latest provided price | $23.92 | FMP | Financial Modeling Prep (FMP) · quote — Dated to the US trading session the price belongs to, derived from the quote record's timestamp (weekend and pre-open reads roll back to the previous weekday; exchange holidays are not modelled). The record does not establish an exchange execution time. Retrieved 2026-10-04T21:04:42.618Z. | |
px.change | Change on the day | +0.46% | FMP | Financial Modeling Prep (FMP) · quote | |
px.mcap | Market capitalisation | $23.4B | FMP | Financial Modeling Prep (FMP) · quote — Date unknown Market cap record date: 2026-10-02. FMP quote timestamp: 2026-10-02T20:00:02.000Z. Captured from FMP at 2026-10-04T21:04:40.591Z. No share-count basis is inferred; this page preserves the reported amount instead of recalculating it from shares. | |
earn.next | Next earnings date | Nov 3, 2026 | FMP | Financial Modeling Prep (FMP) earnings calendar — The date is our provider's estimate until the company confirms it. | |
id.business_summary | Business description (FMP excerpt) | Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment; Connected Care; Personal Health; and Other. | FMP | Financial Modeling Prep (FMP) company profile — Deterministic excerpt derived from id.description; source and date describe the input fact, not a new provider observation | |
px.change_abs | Change on the day, in dollars | +$0.11 | FMP | Financial Modeling Prep (FMP) · quote | |
fin.q_revenue | Revenue, Q2 FY2026 | $4.88B | FMP | Financial Modeling Prep (FMP) · income statement (quarterly) | |
px.pe | Price / earnings (trailing) | 18.18 | FMP | Financial Modeling Prep (FMP) · quote | |
px.volume | Shares traded on the day | 836.3K | FMP | Financial Modeling Prep (FMP) · quote | |
px.beta | Beta | 0.92 | FMP | Financial Modeling Prep (FMP) company profile | |
id.sector | Sector / industry (provider taxonomy) | Healthcare / Medical Devices | FMP | Financial Modeling Prep (FMP) company profile — The company's SEC filings classify it under SIC 3844 — X-Ray Apparatus & Tubes & Related Irradiation Apparatus. | |
id.employees | Employees | 66,401 | FMP | Financial Modeling Prep (FMP) employee count, from the company's filing | |
id.ceo | Chief executive | Roy W. O. Jakobs | FMP | Financial Modeling Prep (FMP) key executives (proxy-derived) — Titles and pay come from the company's proxy statement as our provider parsed it. | |
fin.q_income | Net income, Q2 FY2026 | $429M | FMP | Financial Modeling Prep (FMP) · income statement (quarterly) | |
earn.history.depth.2026-07-27.revenue_actual | Revenue · reported — report date 2026-07-27 | $4.96B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-07-27.revenue_estimated | Revenue · estimate — report date 2026-07-27 | $4.91B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-07-27.eps_actual | EPS · reported — report date 2026-07-27 | $0.5700 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-07-27.eps_estimated | EPS · estimate — report date 2026-07-27 | $0.4000 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-05-06.revenue_actual | Revenue · reported — report date 2026-05-06 | $4.59B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-05-06.revenue_estimated | Revenue · estimate — report date 2026-05-06 | $4.49B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-05-06.eps_actual | EPS · reported — report date 2026-05-06 | $0.2700 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-05-06.eps_estimated | EPS · estimate — report date 2026-05-06 | $0.2400 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-02-10.revenue_actual | Revenue · reported — report date 2026-02-10 | $6.07B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-02-10.revenue_estimated | Revenue · estimate — report date 2026-02-10 | $5.89B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-02-10.eps_actual | EPS · reported — report date 2026-02-10 | $0.7000 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-02-10.eps_estimated | EPS · estimate — report date 2026-02-10 | $0.5650 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-11-04.revenue_actual | Revenue · reported — report date 2025-11-04 | $5.04B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-11-04.revenue_estimated | Revenue · estimate — report date 2025-11-04 | $5.03B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-11-04.eps_actual | EPS · reported — report date 2025-11-04 | $0.3700 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-11-04.eps_estimated | EPS · estimate — report date 2025-11-04 | $0.3700 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
fin.q_table | Quarterly income statement | 4 quarters through Q2 FY2026 | FMP | Financial Modeling Prep (FMP) · income statement (quarterly), as filed | |
own.institutions.depth.ownership_pct | Institutional ownership | 5.4% | FMP | Financial Modeling Prep (FMP) institutional ownership summary, from 13F filings — 13F filings are quarterly and lag the quarter end by up to 45 days. Period end Jun 30, 2026 | |
own.institutions.depth.ownership_pct_previous_quarter | Previous quarter · ownership | 5.4% | FMP | Financial Modeling Prep (FMP) institutional ownership summary, from 13F filings — 13F filings are quarterly and lag the quarter end by up to 45 days. Prior to period end Jun 30, 2026 | |
own.institutions.depth.holders | Reporting holders | 376 | FMP | Financial Modeling Prep (FMP) institutional ownership summary, from 13F filings — 13F filings are quarterly and lag the quarter end by up to 45 days. Period end Jun 30, 2026 | |
own.institutions.depth.holders_previous_quarter | Previous quarter · holders | 352 | FMP | Financial Modeling Prep (FMP) institutional ownership summary, from 13F filings — 13F filings are quarterly and lag the quarter end by up to 45 days. Prior to period end Jun 30, 2026 | |
own.top_holders.depth.holder_0.shares | Mondrian Investment Partners Ltd — shares in provider snapshot | 8,067,528 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied. | |
own.top_holders.depth.holder_1.shares | Dimensional Fund Advisors LP — shares in provider snapshot | 4,340,691 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied. | |
own.top_holders.depth.holder_2.shares | Fiduciary Management INC /Wi/ — shares in provider snapshot | 3,459,961 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied. | |
own.top_holders.depth.holder_3.shares | Causeway Capital Management LLC — shares in provider snapshot | 3,061,962 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied. | |
own.top_holders.depth.holder_4.shares | Morgan Stanley — shares in provider snapshot | 2,935,662 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied. |
UNRECORDED — 4 facts from stored observations whose source was not recorded
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
earn.history | Reported versus estimated, recent quarters | EPS beat 5 of 8 | UNRECORDED | Stored earnings-history observation — Captured 2026-10-03 | |
fin.scores | Distress and quality screens | Altman Z 1.96 · Piotroski F 7 | UNRECORDED | Stored financial-scores observation — Captured 2026-10-04 · Expired observation | |
px.range52 | 52-week range | $23.70 – $33.44 | UNRECORDED | Stored company-profile observation — Captured 2026-10-03 | |
fin.ratios | Return and yield ratios (trailing twelve months) | ROE 10.0% · ROA 4.2% · current ratio 1.26 · earnings yield 5.3% · free-cash-flow yield 8.8% | — | UNRECORDED | Stored key metrics — Date unknown |
COMPUTED — 4 facts from our arithmetic, formula restated
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
div.ttm_per_share | Dividends per share, last 12 months (split-adjusted) | $0.99 | COMPUTED | Financial Modeling Prep (FMP) split-adjusted dividend history — Sum of 1 split-adjusted declared dividend with an ex-date in the 365 days to 2026-10-05, per current share. Ex-dates are not payment dates; special dividends are included. Not a declared annual rate. | |
div.ttm_yield | Dividend yield, last 12 months | 4.14% | COMPUTED | Financial Modeling Prep (FMP) split-adjusted dividend history and quote — Split-adjusted dividends with ex-dates in the trailing 365-day window divided by the packet price, on the same current-share basis. Price date follows the quote, latest price bar or packet-build day when unstamped. Not a forecast or declared annual rate. | |
earn.history.depth.2026-07-27.revenue_actual.comparison | Latest report · revenue vs estimate | Above estimate | Report date · | COMPUTED | Computed from Financial Modeling Prep (FMP) earnings — Earnings-history note — Method: compare reported revenue ($4.96B) with the recorded estimate ($4.91B) at displayed precision. Equal displayed values are in line. This compares reported results with recorded estimates, not investment returns. |
earn.history.depth.2026-07-27.eps_actual.comparison | Latest report · EPS vs estimate | Above estimate | Report date · | COMPUTED | Computed from Financial Modeling Prep (FMP) earnings — Earnings-history note — Method: compare reported EPS ($0.5700) with the recorded estimate ($0.4000) at displayed precision. Equal displayed values are in line. This compares reported results with recorded estimates, not investment returns. |
OURS — 3 facts from Stock Expert AI's own score and rank
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
ours.moonshot | MoonshotScore v2 | 74 of 100 · Strong · pillars 83 / 46 / 84 / 54 / 50 | OURS | Stock Expert AI MoonshotScore v2 engine | |
ours.moonshot_change | MoonshotScore movement | 74 (stored snapshot Oct 4, 2026) → 74 (current publication computed Oct 5, 2026) (0) | OURS | Stock Expert AI current score publication and immutable score snapshots — The current score publication is not yet represented in the immutable snapshot archive. | |
gap.statement_currency | Statement currency limitation | Detailed statement figures are not shown because their conversion to USD has not been verified. | OURS | Stock Expert AI currency-basis check |
Fact-family notes
- Earnings-history note. Source series as of 2026-07-27. Dates are report dates, not fiscal period ends. Revenue is in USD; EPS is USD per share, rounded to four decimals. The earnings feed does not establish a basic, diluted or adjusted basis. Earnings-feed EPS may differ from statement EPS; the two series are not combined. Applies to Fact IDs:
earn.history.depth.2026-07-27.revenue_actual,earn.history.depth.2026-07-27.revenue_estimated,earn.history.depth.2026-07-27.revenue_actual.comparison,earn.history.depth.2026-07-27.eps_actual.comparison,earn.history.depth.2026-07-27.eps_actual,earn.history.depth.2026-07-27.eps_estimated,earn.history.depth.2026-05-06.revenue_actual,earn.history.depth.2026-05-06.revenue_estimated,earn.history.depth.2026-05-06.eps_actual,earn.history.depth.2026-05-06.eps_estimated,earn.history.depth.2026-02-10.revenue_actual,earn.history.depth.2026-02-10.revenue_estimated,earn.history.depth.2026-02-10.eps_actual,earn.history.depth.2026-02-10.eps_estimated,earn.history.depth.2025-11-04.revenue_actual,earn.history.depth.2025-11-04.revenue_estimated,earn.history.depth.2025-11-04.eps_actual,earn.history.depth.2025-11-04.eps_estimated.
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com
Sources used for research written 2026-09-12
Historical evidence preserved with this analysis. Current figures are listed separately above.
| Evidence | Captured value | Source date | Source type | Source |
|---|---|---|---|---|
| Sector / industry (provider taxonomy) | Healthcare / Medical - Devices The company's SEC filings classify it under SIC 3844 — X-Ray Apparatus & Tubes & Related Irradiation Apparatus. | 2026-09-12 | FMP | Financial Modeling Prep (FMP) company profile |
| Business description | Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment; Connected Care; Personal Health; and Other. The Diagnosis and Treatment segment consists of systems, smart devices, software, and services, powered by AI-enabled solutions that support precision diagnoses and minimally invasive treatment in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care segment focuses on Hospital Patient Monitoring, Sleep and Respiratory Care, and Enterprise Informatics. The Personal Health segment represents Oral Healthcare business unit, Personal Care business unit, and Mother and Child Care business unit. The Other segment is involved on the Innovation and Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands. | 2026-09-12 | FMP | Financial Modeling Prep (FMP) company profile |
| Management outlook — dated call excerpts | Captured record · 4 entries
Selected verbatim statements from the latest available call, dated by the transcript provider. Management expectations, not completed milestones or guarantees. Relative dates retain the speaker's wording. | 2026-07-28 | OFFICIAL | Company earnings call, transcript via Financial Modeling Prep (FMP) |
Data provided for informational purposes only.
ETFs that hold PHG
Funds in our ETF coverage that list PHG among the top 10 holdings on their fund page, largest weight first. Each weight is the fund's reported holding weight as of the date in its row.
| ETF | Weight | Holdings as of |
|---|---|---|
| LGHT ETF | 6.53% |